TUSTIN, CA--(Marketwired - Dec 9, 2016) - Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) (NASDAQ: PPHMP), today announced that the company will attend and participate at two upcoming life sciences industry conferences. The company will host a corporate booth in the exhibit hall at KNect365 Life Sciences' Antibody Engineering & Therapeutics conference. In addition, Pete Gagnon, Avid's vice president, process sciences, will present a case study on innovative applications for antibody manufacturing processes at the 16th Annual Global Bioproduction Summit.
Details of these activities are as follows:
KNect365 Life Sciences' Antibody Engineering & Therapeutics: December 11-15, 2016, San Diego, CA
Avid will host corporate booth #209 showcasing the company's comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. These include a variety of innovative processes for generating a broad range of biopharmaceutical product types such as monoclonal antibodies, highly-glycosylated recombinant proteins and enzymes, among others. These capabilities also extend to the manufacture of biosimilar products and are designed to support the overall ongoing growth of the company's contract manufacturing business.
16th Annual Global Bioproduction Summit: December 12-13, 2016, San Diego, CA
Mr. Gagnon will present a case study highlighting the importance of managing keystone contaminants in downstream processing. The presentation, which will take place from 10:55 - 11:25 a.m. (Pacific) on Monday, December 12th, will detail streamlined manufacturing processes for removing chromatin from cell culture harvests to enable improved purification process economics and product quality. The content of this case study showcases the industry-leading manufacturing expertise that Avid offers to its clients.
For additional details on these events, please visit: https://lifesciences.knect365.com/antibody-engineering-therapeutics/ and http://www.biologicalproduction.com/.
About Avid Bioservices
Avid Bioservices provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With over 15 years of experience producing monoclonal antibodies and recombinant proteins in batch, fed-batch and perfusion modes, Avid's services include cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The company also provides a variety of process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization. For more information about Avid, please visit www.avidbio.com.
About Peregrine Pharmaceuticals, Inc.
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of patients by delivering high quality pharmaceutical products through its contract development and manufacturing organization (CDMO) services and through advancing and licensing its investigational immunotherapy and related products. Peregrine's in-house CDMO services, including cGMP manufacturing and development capabilities, are provided through its wholly-owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and biomanufacturing services for both Peregrine and third-party customers. The company is also working to evaluate its lead immunotherapy candidate, bavituximab, in combination with immune stimulating therapies for the treatment of various cancers, and developing its proprietary exosome technology for the detection and monitoring of cancer. For more information, please visit www.peregrineinc.com.